Page last updated: 2024-08-23

bromocriptine and Disruptive, Impulse Control, and Conduct Disorders

bromocriptine has been researched along with Disruptive, Impulse Control, and Conduct Disorders in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's1 (33.33)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Hamidianjahromi, A; Tritos, NA1
Auyeung, M; Cheung, CM; Lee, CN; Li, R; Tang, WK; Tsoi, TH; Yeung, E1
Carriero, NJ; Gorelick, DA; Hall, GW; Montoya, ID; Preston, KL; Takushi, RY1

Reviews

1 review(s) available for bromocriptine and Disruptive, Impulse Control, and Conduct Disorders

ArticleYear
Impulse control disorders in hyperprolactinemic patients on dopamine agonist therapy.
    Reviews in endocrine & metabolic disorders, 2022, Volume: 23, Issue:5

    Topics: Bromocriptine; Cabergoline; Disruptive, Impulse Control, and Conduct Disorders; Dopamine Agonists; Humans; Hyperprolactinemia; Male; Pituitary Neoplasms

2022

Trials

1 trial(s) available for bromocriptine and Disruptive, Impulse Control, and Conduct Disorders

ArticleYear
Pathological gambling among cocaine-dependent outpatients.
    The American journal of psychiatry, 2000, Volume: 157, Issue:7

    Topics: Adolescent; Adult; Age of Onset; Ambulatory Care; Bromocriptine; Bupropion; Carbamazepine; Cocaine-Related Disorders; Comorbidity; Disruptive, Impulse Control, and Conduct Disorders; Female; Gambling; Humans; Length of Stay; Male; Middle Aged; Prevalence; Psychiatric Status Rating Scales; Substance Abuse Detection; Substance Abuse Treatment Centers; Treatment Outcome

2000

Other Studies

1 other study(ies) available for bromocriptine and Disruptive, Impulse Control, and Conduct Disorders

ArticleYear
Impulse control disorders in Chinese Parkinson's disease patients: the effect of ergot derived dopamine agonist.
    Parkinsonism & related disorders, 2011, Volume: 17, Issue:8

    Topics: Aged; Antiparkinson Agents; Asian People; Bromocriptine; China; Cross-Sectional Studies; Disruptive, Impulse Control, and Conduct Disorders; Dopamine Agonists; Drug Therapy, Combination; Ergot Alkaloids; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Prospective Studies

2011